Status:
COMPLETED
Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer
Lead Sponsor:
Bispebjerg Hospital
Collaborating Sponsors:
I.M Daehnfeldt Foundation
Danish Cancer Society
Conditions:
Cancer
Fatigue
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
BACKGROUND: Patients with advanced cancer often suffer from fatigue and other symptoms and problems such as insomnia, appetite loss and pain. Problems that may have great consequences for their quali...
Eligibility Criteria
Inclusion
- Answered "quite a bit" or "very much" to the question "were you tired?" (from EORTC QLQ-C15-PAL)
- Cancer in a palliative phase
- Written informed consent
- Age 18 years or above
Exclusion
- Not capable of understanding or judging information, or fill out a questionnaire
- Untreated anemia (Hb \<= 6,0 mmol/L)
- Untreated hypocalcaemia
- Systolic blood pressure \< 100
- In treatment with coumadin
- Receiving unstable doses of methylphenidate, corticosteroids or sleeping medicine the past two weeks
- TSH \< 0.50 or \> 5.50 mcL/mL
- Pregnant or breast feeding
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00925899
Start Date
October 1 2009
End Date
March 1 2013
Last Update
April 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Palliative Medicine, Bispebjerg Hospital
Copenhagen, Denmark, 2400